Medtronic unveils mobile teaching labs; ReShape snags $15.8M for gastric balloon;

 @FierceMedDev: Roche Dx is slashing jobs as it rethinks its diabetes business. More | Follow @FierceMedDev

 @MarkHFierce: Scientists can produce stem cells in great numbers from cadaver scalp tissue. More | Follow @MarkHFierce

 @DamianFierce: Japan's Sysmex is in talks to buy Dune Medical Devices for $200M, according to a report. More | Follow @DamianFierce

> NinePoint Medical, a 2012 Fierce 15 winner, is touting new data demonstrating its NvisionVLE imaging system to be more effective than standard biopsy protocol. News

> Medtronic ($MDT) is unveiling a fleet of mobile labs that will trek across the country to educate surgeons on how to use the company's spinal technologies. More

> Spinal Restoration has closed a $5 million financing round, planning to use the money to commercialize its Biostat pain management system. Release

> Here's something to add to the list of stenting benefits: Patients who receive percutaneous coronary intervention report improved sex lives. Story

> CardioDx, another Fierce 15 acolyte, cites a new study showing the company's Corus CAD diagnostic is more cost-effective than imaging for patients who may have coronary artery disease. Item

> ReShape Medical pulled in $15.8 million to commercialize anti-obesity gastric balloon. Article

> Japan's Sysmex snagged 510(k) clearance for its XN series of blood hematology analyzers. News

> Boston Scientific ($BSX) is announcing positive results for its Promus drug-eluting stent among patients with long vascular lesions. More

> Researchers have developed a new adhesive paper that could make for low-cost diagnostics available in the developing world. Story

Biotech News

 @FierceBiotech: Hirano bodies may block Alzheimer's-related cell death. More | Follow @FierceBiotech

 @JohnCFierce: So AstraZeneca and Ironwood are getting close. AZ pays $25M in cash, up to $125M in miles for China rights to linaclotide; sharing revenue. | Follow @JohnCFierce

 @RyanMFierce: e-Therapeutics (computer-enabled network pharmacology) has shelved a MRSA candidate to focus on cancer program. More (reg. req.) | Follow @RyanMFierce

> Abbott doubles down on ADC cancer drugs in $245M-plus Seattle Genetics pact. Report

> GSK taps stem cell discovery to spot heart threats early. Story

> Celgene wraps promising PhIII data on new multiple myeloma challenger. Article

Pharma News

@FiercePharma: EMA says it's investigating Roche for possible shortcomings in pharmacovigilance. More | Follow @FiercePharma

> Eisai snags FDA nod for blockbuster hopeful Fycompa. Story

> Roche to shed 100 jobs in diabetes Dx revamp. Item

> Judge orders FDA to let Watson sell generic Actos. Article

Biotech Research News

> Australian scientists grow HIV antibodies in cow's milk. More

> A transplant anti-rejection treatment could be the next cancer drug. Article

> Pluristem's placental stem cells combat fibrosis in preclinical test. Story

> Scientists produced stem cells from cadaver scalp tissue. Item

Pharma Manufacturing News

> China's WuXi AppTec opens biologics plant. More

> Mexico's Neolpharma snags Pfizer Puerto Rico plant. News

> Mylan buying vertically integrated SMS oncology plant. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.